Table of Contents
Credits
Host: Sara Dong
Guests: Arsheena Yassin, Mariya Huralska
Content is based on the CID article featured in this episode although with additional writing by Sara Dong
Edited and Produced by Sara Dong with support from the Infectious Diseases Society of America (IDSA)
Our Guests
Arsheena Yassin, PharmD, BCIDP, AAHIVP
Dr. Arsheena Yassin is an Infectious Disease Pharmacist at Robert Wood Johnson University Hospital in New Jersey. She completed her pharmacy residency in Infectious Diseases at Mount Sinai Hospital and Touro College of Pharmacy in New York.
Mariya Huralska, MD
I was born in Ukraine and made my grand entrance into NYC at the ripe old age of 8. After graduating from medical school at Saba University Medical School in the Netherlands Antilles, I completed Internal Medicine Residency at Detroit Medical Center Huron Valley Sinai Hospital. It was during this time that I realized my passion for infectious diseases, and now I’m in my second year of ID Fellowship at Robert Wood Johnson University Hospital. When I’m not fighting off germs, you can find me unwinding with some guilty pleasure reality TV and soaking up quality time with my friends and family.
Culture
Arsheena enjoys being outside and listening to music (all types depending on mood!)
Mariya shared the Ukranian comedy/satire series “Servant of the People”, starring President Zelenskyy
Consult Notes
Welcome to this Febrile StAR episode!
These StAR episodes feature discussions with authors from State-of-the-Art Review articles from the Clinical Infectious Diseases journal (CID).
This episode is based on: Yassin A, Huralska M, Pogue JM, Dixit D, Sawyer RG, Kaye KS. State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms. Clin Infect Dis. 2023;77(9):e46-e56. doi:10.1093/cid/ciad499
Journal companion article – Executive summary link: Yassin A, Huralska M, Pogue JM, Dixit D, Sawyer RG, Kaye KS. State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms. Clin Infect Dis. 2023;77(9):e46-e56. doi:10.1093/cid/ciad499
Infographics
Goal
Listeners will be able to discuss a framework for identifying patients at risk for multidrug-resistant Gram-negative organism infections
Learning Objectives
After listening to this episode, listeners will be able to:
- Describe the core initial evaluation for management of infections caused by multidrug-resistant Gram negative organisms, with an emphasis on assessing patient history for MDR-GN risk factors
- Discuss how to choose an appropriate empiric antibiotic regimen for a critically ill patient with risk factors for MDR-GN infection
- Discuss the importance of multidisciplinary teams for managing patients with MDR-GN infections while inpatient as well as ensuring safe transition to the outpatient setting
Disclosures
Febrile podcast reports no relevant financial disclosures
Potential conflicts of interest are noted in the CID article as well as reproduced below:
A. Y. and M. H. report no potential conflicts of interest
Other conflicts of interest from article authors who were not featured on the podcast:
J. M. P. reports a grant from Merck and consulting fees from Merck, Shionogi, AbbVie, Entasis, Qpex, Melinta, La Jolla, and VenatoRx.
R. G. S. reports consulting fees from AbbVie and MoInIycke and serving as a board member of the Surgical Infection Society Foundation.
K. S. K. reports a grant from the National Institutes of Health (NIH) and Agency for Healthcare Research and Quality; consulting fees from Shionogi, Allecra, Spero, Qpex, Merck, GSK, VenatoRx, MicuRx, and Entasis; participation on advisory boards for VenatoRx, Entasis, the Division of Microbiology and Infectious Diseases of the NIH, and Meji Seika Pharma; and having stock in Merck.
Citation
Yassin, A., Huralska, M., Dong, S. “#108: StAR: MDR GN”. Febrile: A Cultured Podcast. https://share.descript.com/view/IBXwemVFyrQ